Preclinical Evaluation of 89Zr-Desferrioxamine-Bexmarilimab, a Humanized Antibody Against Common Lymphatic Endothelial and Vascular Endothelial Receptor-1, in a Rabbit Model of Renal Fibrosis

© 2023 by the Society of Nuclear Medicine and Molecular Imaging. Immediate Open Access: Creative Commons Attribution 4.0 International License (CC BY) allows users to share and adapt with attribution, excluding materials credited to previous publications. License: https://creativecommons.org/licenses/by/4.0/. Details: http://jnm.snmjournals.org/site/misc/permission.xhtml.

Author Information

¹Turku PET Centre, University of Turku, Turku, Finland;
²Central Animal Laboratory, University of Turku, Turku, Finland;
³Turku Center for Disease Modeling, University of Turku, Turku, Finland;
⁴Turku PET Centre, Turku University Hospital, Turku, Finland;
⁵Department of Medical Physics, Turku University Hospital, Turku, Finland;
⁶Department of Radiology and Nuclear Medicine, Amsterdam UMC, VU University, Amsterdam, The Netherlands;
⁷Institute of Biomedicine, University of Turku, and Department of Pathology, Turku University Hospital, Turku, Finland;
⁸InFLAMES Research Flagship Center, University of Turku, Turku, Finland;
⁹Department of Chemistry, University of Turku, Turku, Finland; and
¹⁰MediCity Research Laboratory, University of Turku, Turku, Finland

For correspondence or reprints, contact Anne Roivainen (anne.roivainen{at}utu.fi).